Mendra

About Mendra

Mendra is a rare disease therapeutics company that leverages AI to accelerate the clinical development and commercialization of breakthrough medicines for diseases with high unmet need. Their mission is to address the underserved rare and ultra-rare disease space by partnering with academic researchers, biotech, and patient foundations to fund, license, and commercialize therapies, while reducing dependence on Pharma M&A.

Products & Services

Therapeutics for Rare Diseases: Developing innovative medicines for rare and ultra-rare diseases using AI to speed up clinical development and commercialization.

Partnerships for Therapy Development: Collaborating with R&D-stage biotech companies to bring high-potential therapies to market by managing regulatory, clinical, and reimbursement strategies.

Specialties

AI-driven drug development Rare and ultra-rare disease therapeutics Clinical development acceleration Commercialization of therapies Partnerships with biotech and academic researchers

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 82000000 MR: - FA: 82 million FAN: 82000000	D: 2026-01-22 FD: 2026-01-22	5 investors

Series A Latest

2026-01-22

$82.0M

5 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Joshua Grass

Co-founder & Chief Executive Officer

J

Jeff Ajer

Chief Commercial Officer

L

Lalarukh Haris Shaikh

Co-founder & Chief Technology Officer

G

Gregory Balani

Vice President, Business Development

View 1 more team members with Pro

Unlock Full Team Directory

Recent News

Mendra Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised